Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Fesoterodine
Drug ID BADD_D00891
Description Fesoterodine is an antimuscarinic prodrug for the treatment of overactive bladder syndrome.
Indications and Usage For the treatment of overactive bladder (with symptoms of urinary frequency, urgency, or urge incontinence).
Marketing Status Prescription; Discontinued
ATC Code G04BD11
DrugBank ID DB06702
KEGG ID D07226
MeSH ID C526675
PubChem ID 6918558
TTD Drug ID D00BLL
NDC Product Code 47621-025; 50370-0047
Synonyms fesoterodine | toviaz | fesoterodine fumarate
Chemical Information
Molecular Formula C26H37NO3
CAS Registry Number 286930-02-7
SMILES CC(C)C(=O)OC1=C(C=C(C=C1)CO)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Drug hypersensitivity10.01.01.001--Not Available
Dry eye06.08.02.0010.004548%
Dry mouth07.06.01.0020.050027%
Dry skin23.03.03.001--
Dry throat22.02.05.004; 07.06.01.0050.004548%Not Available
Dysgeusia17.02.07.003; 07.14.03.0010.003411%
Dyspepsia07.01.02.0010.004548%
Dysphagia07.01.06.0030.015918%
Dysphonia22.02.05.005; 19.19.03.002; 17.02.08.0040.006822%
Dyspnoea22.02.01.004; 02.01.03.002--
Dyspnoea exertional22.02.01.005; 02.01.03.0030.002274%Not Available
Dysuria20.02.02.0020.019329%
Ear disorder04.03.01.001--Not Available
Electrocardiogram QT interval13.14.05.020--Not Available
Electrocardiogram QT prolonged13.14.05.0040.002274%
Enuresis20.02.02.003; 19.07.04.0010.002274%Not Available
Erythema multiforme23.03.01.003; 10.01.03.0150.004548%
Eye disorder06.08.03.001--Not Available
Face oedema23.04.01.004; 10.01.05.002; 08.01.07.0030.002274%
Fatigue08.01.01.002--
Feeling abnormal08.01.09.0140.011370%Not Available
Flatulence07.01.04.0020.002274%
Fluid retention20.01.02.003; 14.05.06.0020.002274%Not Available
Fracture15.08.02.001; 12.04.02.0010.006822%
Gait disturbance17.02.05.016; 08.01.02.0020.005685%
Gamma-glutamyltransferase increased13.03.01.011--
Gastrooesophageal reflux disease07.02.02.0030.002274%
Gastroenteritis11.01.07.004; 07.19.03.001--Not Available
Gastrointestinal disorder07.11.01.0010.004548%Not Available
Gastrointestinal pain07.01.05.005--
The 3th Page    First    Pre   3 4 5 6 7    Next   Last    Total 8 Pages